Delivery Order SPE2DB22D2206-SPE2DB24FJD22

Award Date 7/11/24
Potential Completion Date 7/12/24
Potential Value $5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,397.51, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of the pharmaceutical product MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. AmerisourceBergen, one of the largest pharmaceutical distribution companies, has an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the...
This federal contract award, valued at $6,502.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The award is a delivery order for the supply of 4565890586 - MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a firm-fixed-price pricing type and an ultimate completion date of September 23, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. government, has been...
This federal contract award, valued at $25,995.98, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has an ultimate completion date of September 10, 2024. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. government, was awarded this delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) awarded a $60,104.65 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with an ultimate completion date of October 11, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, leveraging its extensive supply chain network. This contract is part...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $11,572 firm fixed-price delivery order is for the supply of MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has an ultimate completion date of August 19, 2024. AmerisourceBergen is a major supplier of pharmaceutical and medical products to the U.S. government, holding several Indefinite Delivery Contracts (IDCs) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $8,519.53, is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This is a firm fixed-price delivery order contract with a completion date of May 22, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $28,151.86 firm-fixed-price delivery order is for the supply of MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of October 8, 2024. AmerisourceBergen, as a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of prescription medications, medical...
This federal contract award, valued at $27,904.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. It is a Firm Fixed Price Delivery Order contract with a completion date of September 12, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. government, has been awarded several significant...
This federal contract award, valued at $4,353.44, was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a type of medication. The contract has an ultimate completion date of February 13, 2025 and is a Firm Fixed Price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $18,889.57 firm-fixed-price delivery order is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a completion date of September 10, 2024. AmerisourceBergen, as a major pharmaceutical distributor, has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) by various defense and civilian...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FJD22
    Delivery Order

This federal contract award, valued at $5,049.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a completion date of July 12, 2024. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of medical products to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award does not have a set-aside designation.

Generated 10/10/24, 9:32 AM